Dr. Britt Holderness Olmsted, MD
Hematology & Oncology Physician in White River Junction, VT
NPI: 1629211933Primary Practice Location
White River Junction VAMC
215 N Main St, White River Junction, Vermont, 05001
HQ Phone
Get Dr. Olmsted's Phone Numberphone_androidMobile
Get Dr. Olmsted's MobileAbout Dr. Britt Holderness Olmsted, MD
Technology Used by Dr. Britt Holderness Olmsted, MD
Looking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Dr. Britt Holderness Olmsted, MD Specialties
Dr. Britt Holderness Olmsted, MD Certifications & Licensure
OH State Medical License
NH State Medical License
2012
FL State Medical License
2018 - 2026
OH State Medical License
2015 - 2018

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Hematology

American Board of Internal Medicine
Medical Oncology
Dr. Britt Holderness Olmsted, MD Education & Trainingkeyboard_arrow_up
Dartmouth-Hitchcock/Mary Hitchcock Memorial Hospital
dartmouth-hitchcock.org
Fellowship • Hematology and Medical Oncology
2012 - 2015
Residency • Internal Medicine
2009 - 2012
Ross University School of Medicine
medical.rossu.edu
Medical School
Until 2008
Dr. Britt Holderness Olmsted, MD Publications
Authors: Camilo Fadul
Journal: Oncologist
Publication Date: 2015-07-23
Thromboprophylaxis and Outcomes for Total Joint Arthroplasty in Congenital Bleeding Disorders A Single-Center Experience
Authors: Britt M. Holderness, Yuika Goto, Laurel Mckernan, Philip M. Bernini, Deborah L. Ornstein
Publication Date: 2016-04
Authors: Marc Ernstoff
Journal: Anticancer Res
Dr. Britt Holderness Olmsted, MD Clinical Trials1 Clinical Trialkeyboard_arrow_up
Lead Sponsor: SWOG Cancer Research Network
Collaborators: National Cancer Institute (NCI), Cancer Prevention Pharmaceuticals, Inc.
Intervention / Treatment: DRUG: Eflornithine plus sulindac, DRUG: Eflornithine placebo & sulindac placebo, DRUG: eflornithine & sulindac placebo, DRUG: Eflornithine placebo & sulindac